Home › Valeant, AstraZeneca strike psoriasis deal
 

Keywords :   


Valeant, AstraZeneca strike psoriasis deal

2015-09-01 13:41:52| Biotech - Topix.net

Canada's Valeant Pharmaceuticals International Inc. has struck a deal with AstraZeneca PLC for the rights to sell psoriasis treatment brodalumab after Amgen Inc. dropped its own collaboration with the U.K.-based drug maker over concerns about the drug's side effects. Valeant said on Tuesday that it will pay AstraZeneca $100 million upfront, with another $170 million in prelaunch milestones and up to $175 million following launch.

Tags: deal strike psoriasis astrazeneca

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05IT Cosmetics and Kenvue Launch New Products
19.05Virgin Trains targets West Coast in return to rail
19.05Cashing In On The Stache
19.05 Dr. Squatch Launches Bronco Bricc
19.05Gillette Venus Announces Ambassadors Ahead of the Olympic and Paralympic Games Paris 2024
19.05Eastern North Pacific Tropical Weather Outlook
More »